Clinical trial
Cannabidivarin (CBDV) vs. Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
NCT03848481 is registered in ClinicalTrials.gov with Eric Hollander as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cannabidivarin (CBDV) vs. Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
- Lead sponsor
- Eric Hollander
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 23, 2020
- Completion date
- October 31, 2024
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.